AIs suppress estrogen synthesis by inhibiting aromatase activity, thereby inhibiting breast cancer cell growth; however, they may further reduce systemic estrogen levels, potentially aggravating bone loss (6). This evidence concerns the gene CYP19A1 and breast cancer.